Literature DB >> 12198811

Potential mechanisms of neuropathic pain in diabetes.

Nigel A Calcutt1.   

Abstract

Abnormal sensations and pain are features of approximately 10% of all cases of diabvetic neuropathy and can cause marked diminution in the quality of life for these patients. The quality and distribution of pain are variable, although descriptions of burning pain in the hands and feet are commonly reported. Like other neuropathic pain states, painful diabetic neuropathy has an unknown pathogenesis and, in many cases, is not alleviated by nonsteriodal anti-inflammatory drugs or opiates. In the last decase, a number of behavioral and physiologic studies have revealed indices of sensory dysfunction in animal models of diabetes. These include hyperalgesia to mechanical and noxious chemical stimuli and allodynia to light touch. Animal models of painful diabetic neuropathy have been used to investigate the therapeutic potential of a range of experimental agents and also to explore potential etiologic mechanisms. There is relatively little evidence to suggest that the peripheral sensory nerves of diabetic rodents exhibit spontaneous activity or increased responsiveness to peripheral stimuli. Indeed, the weight of eveidence suggests that sensory input to the spinal cord is decreased rather than increased in diabetic rodents. Aberrant spinal or supraspinal modulation of sensory processing may therefore be involved in generating allodynia and hyperalgesia in these models. Studies have supported a role for spinally mediated hyeralgesia in diabetic rats that may reflect either a response to diminished peripheral input or a consequence of hyperglycemia on local or descending modulatory systems. Elucidating the affects of diabetes on spinal sensory processing may assist development of novel therapeutic strategies for preventing and alleviating painful diabetic neuropathy.

Entities:  

Mesh:

Year:  2002        PMID: 12198811     DOI: 10.1016/s0074-7742(02)50078-7

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  41 in total

1.  Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy.

Authors:  M M Jack; J M Ryals; D E Wright
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

2.  Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

Authors:  Y Jiang; A P Mizisin; A Rearden; C G Jolivalt
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

3.  Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Sergey Lupachyk; Alexander Obrosov; John T Groves; Irina G Obrosova; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

4.  Longitudinal relationship between onset of physical symptoms and functional impairment.

Authors:  Lisa M McAndrew; Drew A Helmer; Shou-En Lu; Helena K Chandler; Sarah Slotkin; Karen S Quigley
Journal:  J Behav Med       Date:  2018-06-09

Review 5.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 6.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

7.  Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.

Authors:  N A Calcutt; J D Freshwater; A P Mizisin
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 8.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Authors:  T S Kern; C M Miller; J Tang; Y Du; S L Ball; L Berti-Matera
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

10.  Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.

Authors:  James F McGuire; Shefali Rouen; Eric Siegfreid; Douglas E Wright; Rick T Dobrowsky
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.